Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
7.97
-0.32 (-3.80%)
Mar 31, 2025, 3:09 PM EDT - Market open

Sage Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4903321,3012,2692,5064,502
Upgrade
Market Cap Growth
-74.47%-74.47%-42.67%-9.45%-44.34%20.36%
Upgrade
Enterprise Value
-4-2274328896833,864
Upgrade
Last Close Price
8.285.4321.6738.1442.5486.51
Upgrade
PE Ratio
-----7.43
Upgrade
PS Ratio
12.208.0515.05295.22397.274.04
Upgrade
PB Ratio
1.090.711.631.811.452.17
Upgrade
P/TBV Ratio
0.710.711.631.811.452.17
Upgrade
P/FCF Ratio
----6.78
Upgrade
P/OCF Ratio
----6.78
Upgrade
EV/Sales Ratio
-5.00115.69108.233.47
Upgrade
EV/EBITDA Ratio
----6.17
Upgrade
EV/EBIT Ratio
----6.19
Upgrade
EV/FCF Ratio
----5.82
Upgrade
Debt / Equity Ratio
0.030.030.010.010.010.01
Upgrade
Debt / EBITDA Ratio
-----0.04
Upgrade
Debt / FCF Ratio
-----0.04
Upgrade
Asset Turnover
0.060.060.080.010.000.69
Upgrade
Inventory Turnover
--224.00210.95--
Upgrade
Quick Ratio
7.227.2210.1712.9720.6831.24
Upgrade
Current Ratio
7.427.4210.5113.4721.1431.58
Upgrade
Return on Equity (ROE)
-63.37%-63.37%-52.77%-35.74%-24.09%40.18%
Upgrade
Return on Assets (ROA)
-35.90%-35.90%-30.51%-21.49%-14.46%24.05%
Upgrade
Return on Capital (ROIC)
-40.04%-40.04%-33.01%-22.70%-14.97%25.30%
Upgrade
Return on Capital Employed (ROCE)
-----29.80%
Upgrade
Earnings Yield
-81.92%-120.62%-41.62%-23.48%-18.27%13.46%
Upgrade
FCF Yield
-54.63%-80.44%-41.60%-20.32%-15.11%14.75%
Upgrade
Buyback Yield / Dilution
-1.55%-1.55%-0.89%-1.08%-10.69%-4.27%
Upgrade
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q